Novel Approach Holds Huge Promise for Diabetes Patients
The latest advance for vascular surgeon, Darwin Eton, MD, is growing arteries in patients with narrowed and blocked vessels. This cutting-edge research promises to change how we treat circulatory problems common to some of our most debilitating diseases, including arteriosclerosis and diabetes, one of the biggest epidemics medicine currently faces.
Shifting the Odds on Ovarian Cancer
A University of Chicago-led research team recently identified a critical driver behind the spread of ovarian cancer, including a potential new drug target. Principal investigator, Ernst Lengyel, MD, PhD, explains the work.
Drug Treatment Could Replace Surgery for Brain Disorder
A new drug treatment that neurosurgeon Issam Awad, MD, and his collaborators discovered has for the first time prevented lesions from developing in animals.
“This is a huge breakthrough,” says Awad. “Uniformly, my patients are excited about this because they’ve had a disease that’s had no medicine up until now."
Radiation or Chemo? The Answer May Be Around the Corner
Getting the right treatment early can make all the difference for cancer patients. But what is the best approach? New research from a University of Chicago-led team could predict whether patients with advanced cancers will respond to radiation. For patients and their doctors who are considering what treatment course to take, these findings could be lifesaving.
The latest advance for vascular surgeon, Darwin Eton, MD, is growing arteries in patients with narrowed and blocked vessels. This cutting-edge research promises to change how we treat circulatory problems common to some of our most debilitating diseases, including arteriosclerosis and diabetes, one of the biggest epidemics medicine currently faces. 
A University of Chicago-led research team recently identified a critical driver behind the spread of ovarian cancer, including a potential new drug target. Principal investigator, Ernst Lengyel, MD, PhD, explains the work.
A new drug treatment that neurosurgeon Issam Awad, MD, and his collaborators discovered has for the first time prevented lesions from developing in animals.
Getting the right treatment early can make all the difference for cancer patients. But what is the best approach? New research from a University of Chicago-led team could predict whether patients with advanced cancers will respond to radiation. For patients and their doctors who are considering what treatment course to take, these findings could be lifesaving. 
